AKT1 and neurodegenerative disease: Epigallocatechin-3-gallate promotes dendritic growth and synaptogenesis through selective inhibition of the AKT/mTOR signaling pathway, inhibits acetylcholinesterase activity, and effectively ameliorates neurological damage in neurodegenerative diseases.